3 Stocks That May Be Priced Below Their Estimated Intrinsic Value

Simply Wall St.
2024-12-30

As global markets navigate a period of mixed economic signals, including a dip in U.S. consumer confidence and fluctuating stock index performances, investors are increasingly focused on identifying opportunities that may be undervalued amidst these uncertainties. In this context, finding stocks priced below their estimated intrinsic value can offer potential for growth, especially when broader market conditions present both challenges and opportunities.

Top 10 Undervalued Stocks Based On Cash Flows

Name Current Price Fair Value (Est) Discount (Est)
Corporativo Fragua. de (BMV:FRAGUA B) MX$631.28 MX$1257.07 49.8%
SKS Technologies Group (ASX:SKS) A$1.935 A$3.85 49.7%
Shenzhen Lifotronic Technology (SHSE:688389) CN¥15.45 CN¥30.82 49.9%
Sudarshan Chemical Industries (BSE:506655) ₹1130.65 ₹2253.01 49.8%
Lindab International (OM:LIAB) SEK228.20 SEK452.08 49.5%
S Foods (TSE:2292) ¥2757.00 ¥5472.35 49.6%
Pluk Phak Praw Rak Mae (SET:OKJ) THB15.50 THB30.86 49.8%
Infomart (TSE:2492) ¥290.00 ¥574.47 49.5%
Surgical Science Sweden (OM:SUS) SEK159.60 SEK317.20 49.7%
SkyCity Entertainment Group (NZSE:SKC) NZ$1.45 NZ$2.90 49.9%

Click here to see the full list of 871 stocks from our Undervalued Stocks Based On Cash Flows screener.

Below we spotlight a couple of our favorites from our exclusive screener.

ASML Holding

Overview: ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems for chipmakers and has a market cap of approximately €269.18 billion.

Operations: ASML generates revenue of €26.24 billion from its semiconductor equipment and services segment.

Estimated Discount To Fair Value: 11.5%

ASML Holding is trading at €684.9, below its estimated fair value of €773.65, suggesting potential undervaluation based on cash flows. Despite high volatility and legal challenges over alleged misrepresentations, ASML's earnings are projected to grow faster than the Dutch market at 18.3% annually. However, revenue growth is slower than desired and recent export restrictions impact Chinese sales negatively affecting margins. Analysts expect a stock price rise of 23.7%, indicating confidence in future performance improvement despite current challenges.

  • Our earnings growth report unveils the potential for significant increases in ASML Holding's future results.
  • Unlock comprehensive insights into our analysis of ASML Holding stock in this financial health report.
ENXTAM:ASML Discounted Cash Flow as at Dec 2024

CVC Capital Partners

Overview: CVC Capital Partners plc is a private equity and venture capital firm that focuses on middle market secondaries, infrastructure and credit, management buyouts, leveraged buyouts, growth equity, mature investments, recapitalizations, strip sales, and spinouts with a market cap of €22.37 billion.

Operations: CVC Capital Partners plc generates revenue through its specialization in private equity and venture capital activities, including middle market secondaries, infrastructure and credit investments, management buyouts, leveraged buyouts, growth equity ventures, mature investments, recapitalizations, strip sales, and spinouts.

Estimated Discount To Fair Value: 24.1%

CVC Capital Partners, trading at €21.04, is significantly undervalued compared to its estimated fair value of €27.71. The company is poised for robust growth with earnings projected to rise 41.67% annually, outpacing the Dutch market's 15.7%. Despite high debt levels, CVC's strong cash flow and potential acquisition of Vivendi SE’s stake in Telecom Italia could enhance its strategic position. However, ongoing M&A activities may present integration challenges and financial strain.

  • Our growth report here indicates CVC Capital Partners may be poised for an improving outlook.
  • Click to explore a detailed breakdown of our findings in CVC Capital Partners' balance sheet health report.
ENXTAM:CVC Discounted Cash Flow as at Dec 2024

Safran

Overview: Safran SA, along with its subsidiaries, operates in the aerospace and defense sectors globally and has a market capitalization of €88.70 billion.

Operations: The company's revenue is primarily derived from Aerospace Propulsion (€12.66 billion), Aeronautical Equipment, Defense and Aerosystems (€9.91 billion), and Aircraft Interiors (€2.73 billion).

Estimated Discount To Fair Value: 27.6%

Safran is trading at €211, significantly below its estimated fair value of €291.54, suggesting it is undervalued based on cash flows. Despite a lowered revenue guidance to €27.1 billion for 2024, earnings are forecasted to grow annually by 19.3%, outpacing the French market's growth rate. The company’s strategic focus on bolt-on acquisitions aims to strengthen core businesses and enhance future profitability, although profit margins have recently declined from last year’s levels.

  • Our comprehensive growth report raises the possibility that Safran is poised for substantial financial growth.
  • Take a closer look at Safran's balance sheet health here in our report.
ENXTPA:SAF Discounted Cash Flow as at Dec 2024

Taking Advantage

  • Explore the 871 names from our Undervalued Stocks Based On Cash Flows screener here.
  • Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
  • Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Looking For Alternative Opportunities?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
  • Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ENXTAM:ASML ENXTAM:CVC and ENXTPA:SAF.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10